Results 131 to 140 of about 177,602 (172)

A comprehensive analysis of bone marrow-derived cytogenetic abnormalities in multiple myeloma patients with extramedullary disease. [PDF]

J Cancer Res Clin Oncol
Xu J, Yang H, Huang J, Niu T, Sun C, Zhang L, Zheng Y.   +6 more
europepmc   +1 more source

HOXB5 in precision oncology: regulatory networks, functional duality, and clinical prospects. [PDF]

J Transl Med
Zhong K, Yi Q, Chen Z, Xu Y, Zeng Y, Zhong J.   +5 more
europepmc   +1 more source

Emerging role of histone and non-histone lactylation in metabolic reprogramming of female-specific malignancies. [PDF]

World J Surg Oncol
Sun C, Hu D, Peng W, Cui Z, Lin Y.
europepmc   +1 more source

Advances in liquid biopsy for bone and soft-tissue sarcomas. [PDF]

Int J Clin Oncol
Wang Y, Fujiwara T, Kurozumi T, Ando T, Ishimaru T, Kondo H, Nakata E, Kunisada T, Ozaki T.   +8 more
europepmc   +1 more source

20 years of taxane therapy in prostate cancer - the past, present and future. [PDF]

Nat Rev Urol
Carceles-Cordon M, Rodriguez-Bravo V, Petrylak DP, Domingo-Domenech J.   +3 more
europepmc   +1 more source

CDK4/6 Inhibitors for Breast Cancer Therapy-A Review of Clinical Trials, Structural and Computational Approaches. [PDF]

Pharmaceuticals (Basel)
Avdičević A, Lešnik S, Bren U, Čavka L.   +3 more
europepmc   +1 more source

The rise of dehydrated ginsenosides: phytochemistry and pharmacology. [PDF]

J Adv Res
Wang KH, Liu JY, Ma LJ, Zhang FX, Wan JB.   +4 more
europepmc   +1 more source

Thyroid hormone signaling in ocular development and diseases. [PDF]

Biol Res
Zhang P, Nie Y, Lu NJ, Jiao Q, Wang X, Zhang X, Liu L.   +6 more
europepmc   +1 more source

Characterisation of an autochthonous mouse ccRCC model of immune checkpoint inhibitor therapy resistance. [PDF]

Sci Rep
Peighambari A, Huang H, Metzger P, Adlesic M, Zodel K, Schäfer S, Seidel P, Braun LM, Hülsdünker J, Melchinger W, Follo M, Ku M, Haug S, Li Y, Köttgen A, Schell C, von Elverfeldt D, Reichardt W, Zeiser R, Heikenwalder M, Höfflin R, Börries M, Frew IJ.   +22 more
europepmc   +1 more source